Computational analysis of aspartic protease plasmepsin II complexed with EH58 inhibitor: a QM/MM MD study.
Plasmepsin (PM) II is one of four enzymes in the food vacuole of Plasmodium falciparum. It has become an attractive target for combating malaria through research regarding its importance in the P. falciparum metabolism and life cycle, making it the target of choice for structure-based drug design. This paper reports the results of hybrid quantum mechanics / molecular mechanics (QM/MM) molecular dynamics (MD) simulations employed to study the details of the interactions established between PM II and N-(3-{(2-benzo[1, 3]dioxol-5-yl-ethyl)[3-(1-methyl-3-oxo-1,3-dihydro-isoindol-2-yl) propionyl]-amino}-1-benzyl-2-(hydroxyl-propyl)-4-benzyloxy-3,5dimethoxy-benzamide (EH58), a well-known potent inhibitor for this enzyme. Electrostatic binding free energy and energy terms decomposition have been computed for PM II complexed with the EH58 inhibitor. The results reveal that there is a strong interaction between Asp34, Val78, Ser79, Tyr192 and Asp214 residues and the EH58 inhibitor. In addition, we have computed the potential of the mean force (PMF) profile in order to assign the protonation state of the two catalytic aspartates in PM II-EH58 complex. The results indicate that the protonation of Asp214 favors a stable active site structure, which is consistent with our electrostatic binding free energy calculation and with previous published works.
Laboratório de Planejamento e Desenvolvimento de Fármacos, Instituto de Ciências Exatas e Naturais, Universidade Federal do Pará, UFPA, Rua Augusto Corrêa, 01, Guamá CEP, 66075-110 Belém, PA, Brazil.
Natália
N
de Farias Silva
Jerônimo
J
Lameira
Cláudio Nahum
CN
Alves
D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors* / Q000737:chemistry*; D001549:Benzamides / Q000737:chemistry*; D020134:Catalytic Domain; D008968:Molecular Conformation; D056004:Molecular Dynamics Simulation; D010797:Phthalimides / Q000737:chemistry*; D011480:Protease Inhibitors / Q000737:chemistry*; D011485:Protein Binding; D011522:Protons; D015800:Protozoan Proteins / Q000037:antagonists & inhibitors* / Q000737:chemistry*; D011789:Quantum Theory; D014867:Water / Q000737:chemistry
D001549:Benzamides; C570102:N-(3-((2-benzo(1,3)dioxol-5-ylethyl)(3-(1-methyl-3-oxo-1,3-dihydroisoindol-2-yl)propionyl)amino)-1-benzyl-2-(hydroxylpropyl))-4-benzyloxy-3,5-dimethoxybenzamide; D010797:Phthalimides; D011480:Protease Inhibitors; D011522:Protons; D015800:Protozoan Proteins; D014867:Water; D016282:Aspartic Acid Endopeptidases; C100637:plasmepsin II
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10034-9
8816746
J Comput Chem. 2008 Aug;29(11):1840-9
18351589
Bioorg Med Chem. 2005 Sep 15;13(18):5371-90
16054370
J Mol Model. 2011 Feb;17(2):401-13
20490879
Cell Mol Life Sci. 2007 Sep;64(17):2285-305
17585371
Biophys J. 2008 Apr 1;94(7):2443-51
17981909
ChemMedChem. 2007 Jul;2(7):944-86
17530725
Bioorg Med Chem. 2003 Aug 15;11(17):3723-33
12901917
Angew Chem Int Ed Engl. 2009;48(7):1198-229
19173328
FEBS Lett. 2007 Aug 21;581(21):4120-4
17689534
J Mol Biol. 2003 Mar 14;327(1):173-81
12614616
Adv Exp Med Biol. 1998;436:363-73
9561243
Curr Top Med Chem. 2010;10(1):33-45
19929831
Lancet. 1993 Mar 27;341(8848):793
8096003
J Exp Med. 1991 Apr 1;173(4):961-9
2007860
J Phys Chem B. 2010 May 27;114(20):7029-36
20429600
J Comput Chem. 2005 Oct;26(13):1347-58
16021597
ChemMedChem. 2008 Sep;3(9):1323-36
18752222
Protein Sci. 1999 Oct;8(10):2001-9
10548045
J Mol Biol. 1994 May 6;238(3):415-36
8176733
FEBS Lett. 2006 Oct 30;580(25):5910-6
17045991
Biochemistry. 2006 Jun 27;45(25):7709-23
16784222
Trends Parasitol. 2001 Nov;17(11):532-7
11872398
Biochemistry. 2003 Jul 22;42(28):8459-64
12859191
J Phys Chem B. 2008 Nov 13;112(45):14260-6
18939790
J Pept Res. 2005 Oct;66(4):211-9
16138859
Bioorg Med Chem. 2007 Jun 1;15(11):3818-24
17420131
Chemistry. 2007;13(27):7715-24
17570717
Annu Rev Microbiol. 1997;51:97-123
9343345
J Med Chem. 1999 Apr 22;42(8):1428-40
10212129
Antimicrob Agents Chemother. 2006 Feb;50(2):639-48
16436721
Science. 1992 Oct 23;258(5082):631-5
1411573
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):990-5
11782538
Biochemistry. 2004 Nov 23;43(46):14521-8
15544322
Bioorg Med Chem Lett. 1998 Sep 8;8(17):2315-20
9873534
Adv Exp Med Biol. 1998;436:375-80
9561244
Bioorg Med Chem Lett. 1998 Nov 17;8(22):3203-6
9873703
Curr Top Med Chem. 2010;10(1):46-54
19929827
Proteins. 2005 Dec 1;61(4):704-21
16231289